New RCSI-led study seeks to understand Cystic Fibrosis in young children in ‘new era’ of care

Major new study led by RCSI & CHI has been awarded funding of €5.6M to build a better understanding of cystic fibrosis

By Danielle Norton October 19, 2023 Updated January 4, 2024 4 min read

REPRO FREE - NO REPRO FEE Irish researchers to lead €5.6M million study on cystic fibrosis in young children Wednesday, 18 October 2023 – Picture shows Isaac Byrne (aged 2) who has cystic fibrosis with Paul McNally, Associate Professor of Paediatrics at RCSI and Consultant in Respiratory Medicine at Children’s Health Ireland (CHI) at the launch of a major new study that has been awarded funding of €5.6M to work with babies and children in Ireland and the UK over the next five years to build a better understanding of cystic fibrosis. Led by RCSI University of Medicine and Health Sciences and CHI, the ENHANCE study will be carried out at 13 paediatric cystic fibrosis clinics in Ireland and the UK. The project has been awarded $5.9M by the Cystic Fibrosis Foundation (USA), £100,000 by Cystic Fibrosis Trust (UK) with patient partnership support from Cystic Fibrosis Ireland. © Patrick Bolger For further information, please contact: Jane Butler, RCSI Communications Manager, janebutler@rcsi.ie +353 (0)87-7531877

A major new study led by RCSI University of Medicine and Health Sciences and Children’s Health Ireland (CHI) has been awarded funding of €5.6M to work with babies and children in Ireland and the UK over the next five years to build a better understanding of cystic fibrosis.

Children born in the 2020s with cystic fibrosis often have more treatment options and potentially better outcomes than those born with the disease in previous decades. But there is still much we need to understand about cystic fibrosis in babies and children in this new era of care.